Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer

Y. J. Park, E. H. Koh, J. Kim, J. K. Roh, J. Chang, C. M. Ahn, H. Y. Sohn, W. Y. Lee, K. Kim, C. O. Suh, G. E. Kim, J. J.K. Loh, B. S. Kim

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer'. Together they form a unique fingerprint.